NCT01166724 Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression- Status TERMINATED Phase PHASE3
NCT01166555 Pharmacokinetics And Tolerability Of Subcutaneous Administration Of PF 04236921 In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01165736 To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity Status COMPLETED Phase PHASE1
NCT01165723 A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated Status COMPLETED Phase PHASE1
NCT01164579 Effects of Tofacitinib (CP-690,550) on Magnetic Resonance Imaging (MRI)- Assessed Joint Structure In Early Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT01163851 Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin Status COMPLETED Phase PHASE1
NCT01163838 Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia Status WITHDRAWN Phase PHASE1
NCT01163253 A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis Status TERMINATED Phase PHASE3
NCT01162889 Study To Assess The Safety And Tolerability Of Increasing Single Doses Of ATR-107 (PF-05230900) In Healthy People Status TERMINATED Phase PHASE1
NCT01161472 A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects Status COMPLETED Phase PHASE1
NCT01161069 A Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03049423 In Healthy Adult Volunteers And Healthy Older Volunteers Status COMPLETED Phase PHASE1
NCT01159626 Pharmacokinetics, Safety and Tolerability Study of PF-03463275 in Healthy Male Japanese and Western Subjects Status COMPLETED Phase PHASE1
NCT01159496 Multiple Ascending Dose Study To Assess Safety, Tolerability And Pharmacokinetics Of PF-05212377 (SAM-760) Status COMPLETED Phase PHASE1
NCT01157559 Efficacy and Safety With Ziprasidone in First-episode Psychosis Status COMPLETED Phase PHASE4
NCT01155063 Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients Status TERMINATED Phase N/A
NCT01154218 Bioequivalence And Food Effect Study Comparing The Commercial Formulation Of Crizotinib To Its Clinical Study Formulations And Commercial Formulation With Or Without Food In Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01154140 A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung Status COMPLETED Phase PHASE3